News Releases

Clinicians may be better able to diagnose, monitor, and treat sarcoidosis—a rare systemic disease—thanks to new research from Penn Medicine scientists.

The findings could be used to develop topical or bacterial-based treatments for patients with wounds that do not heal well on their own.

Adults with atopic dermatitis have an increased risk of developing new-onset inflammatory bowel disease compared with individuals who do not have the skin condition, according to a new Penn study.

New data from researchers at the Perelman School of Medicine shows apremilast could help people with psoriasis shed unhealthy body fat and therefore improve cardiovascular health.

New research from the Perelman School of Medicine highlights two new potential therapeutic targets for melanoma.

An experimental drug called litifilimab could be a powerful long-term treatment for a form of lupus that occurs in the skin and can impact quality of life.

Patients who undergo facial surgery think their surgical scars look worse than surgeons and independent observers do, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

Targeting pathways altered by MLL4 mutations to induce proper cell turnover and death offers an approach to suppress tumor growth, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. The study was published this month in the journal Science Advances.